Cargando…
Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
SIMPLE SUMMARY: PTK7 is a catalytically defective receptor protein tyrosine kinase. We previously demonstrated that PTK7 enhances angiogenesis by interacting with KDR, a vascular endothelial growth factor (VEGF) receptor important for angiogenesis, and activating it through oligomerization. To contr...
Autores principales: | Oh, Si Won, Shin, Won-Sik, Lee, Seung-Taek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496920/ https://www.ncbi.nlm.nih.gov/pubmed/36139622 http://dx.doi.org/10.3390/cancers14184463 |
Ejemplares similares
-
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
por: Kim, Jae Hoon, et al.
Publicado: (2022) -
Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
por: Shin, Won-Sik, et al.
Publicado: (2018) -
Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF
por: Shin, Won-Sik, et al.
Publicado: (2019) -
Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
por: Shin, Won-Sik, et al.
Publicado: (2023) -
PTK7 Faces the Wnt in Development and Disease
por: Berger, Hanna, et al.
Publicado: (2017)